Karim Saad Temsamani - Sep 7, 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Sep 7, 2023
Transactions value $
-$2,888,067
Form type
4
Date filed
9/11/2023, 04:02 PM
Previous filing
Sep 5, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Sale -$1.44M -85.4K -23.68% $16.90 275K Sep 7, 2023 Direct F1, F2
transaction CDLX Common Stock Sale -$1.44M -81.5K -29.62% $17.71 194K Sep 8, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on September 1, 2023.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.43 to $17.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $17.26 to $18.25, inclusive.